Hirakawa H - Search Results

1

Cancer stem-like properties of hormonal therapy-resistant breast cancer cells.

Uchiumi K, Tsuboi K, Sato N, Ito T, Hirakawa H, Niwa T, Yamaguchi Y, Hayashi SI. Uchiumi K, et al. Among authors: hirakawa h. Breast Cancer. 2019 Jul;26(4):459-470. doi: 10.1007/s12282-018-00944-1. Epub 2019 Jan 4. Breast Cancer. 2019. PMID: 30610551

2

Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.

Suzuki T, Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H, Ohuchi N, Sasano H. Suzuki T, et al. Among authors: hirakawa h. Cancer Res. 2004 Jul 1;64(13):4670-6. doi: 10.1158/0008-5472.CAN-04-0250. Cancer Res. 2004. PMID: 15231680

3

Ductal Carcinoma in situ and related lesions of the breast: recent advances in pathology practice.

Moriya T, Hirakawa H, Suzuki T, Sasano H, Ohuchi N. Moriya T, et al. Among authors: hirakawa h. Breast Cancer. 2004;11(4):325-33. doi: 10.1007/BF02968038. Breast Cancer. 2004. PMID: 15604986 Review.

4

5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production.

Suzuki T, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S, Sasano H. Suzuki T, et al. Among authors: hirakawa h. Int J Cancer. 2007 Jan 15;120(2):285-91. doi: 10.1002/ijc.22317. Int J Cancer. 2007. PMID: 17066438

5

Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.

Miki Y, Suzuki T, Tazawa C, Yamaguchi Y, Kitada K, Honma S, Moriya T, Hirakawa H, Evans DB, Hayashi S, Ohuchi N, Sasano H. Miki Y, et al. Among authors: hirakawa h. Cancer Res. 2007 Apr 15;67(8):3945-54. doi: 10.1158/0008-5472.CAN-06-3105. Cancer Res. 2007. PMID: 17440110

6

Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor.

Suzuki T, Inoue A, Miki Y, Moriya T, Akahira J, Ishida T, Hirakawa H, Yamaguchi Y, Hayashi S, Sasano H. Suzuki T, et al. Among authors: hirakawa h. Endocr Relat Cancer. 2007 Jun;14(2):279-92. doi: 10.1677/ERC-06-0005. Endocr Relat Cancer. 2007. PMID: 17639044

7

Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment.

Takagi K, Miki Y, Nagasaki S, Hirakawa H, Onodera Y, Akahira J, Ishida T, Watanabe M, Kimijima I, Hayashi S, Sasano H, Suzuki T. Takagi K, et al. Among authors: hirakawa h. Endocr Relat Cancer. 2010 Apr 21;17(2):415-30. doi: 10.1677/ERC-09-0257. Print 2010 Jun. Endocr Relat Cancer. 2010. PMID: 20228125

8

Nudix-type motif 2 in human breast carcinoma: a potent prognostic factor associated with cell proliferation.

Oka K, Suzuki T, Onodera Y, Miki Y, Takagi K, Nagasaki S, Akahira J, Ishida T, Watanabe M, Hirakawa H, Ohuchi N, Sasano H. Oka K, et al. Among authors: hirakawa h. Int J Cancer. 2011 Apr 15;128(8):1770-82. doi: 10.1002/ijc.25505. Int J Cancer. 2011. PMID: 20533549

9

Molecular morphological approach to the pathological study of development and advancement of human breast cancer.

Moriya T, Kanomata N, Kozuka Y, Hirakawa H, Kimijima I, Kimura M, Watanabe M, Sasano H, Ishida T, Ohuchi N, Kurebayashi J, Sonoo H. Moriya T, et al. Among authors: hirakawa h. Med Mol Morphol. 2010 Jun;43(2):67-73. doi: 10.1007/s00795-010-0504-5. Epub 2010 Aug 4. Med Mol Morphol. 2010. PMID: 20683691 Review.

10

Androgens in human breast carcinoma.

Suzuki T, Miki Y, Takagi K, Hirakawa H, Moriya T, Ohuchi N, Sasano H. Suzuki T, et al. Among authors: hirakawa h. Med Mol Morphol. 2010 Jun;43(2):75-81. doi: 10.1007/s00795-010-0494-3. Epub 2010 Aug 4. Med Mol Morphol. 2010. PMID: 20683693 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

782 results

Search Page

Filters